The island’s landmark 2018 legislation for industrial scale production and export has already served to entice in as many as 26 heavyweight, big brand cannabinoid-based pharma MNCs.
Many believe that establishing a foothold in this niche will not only trigger a second coming of the local pharmaceutical sector, but deliver much needed shot in the arm for the island’s agro-industry as well. New capital investments have already been placed to the tune of EUR 150 million and the authorities are predicting employment creation of around 1,000 full time jobs within the next 3 years, not to mention growth of auxiliary industries right along the value chain that can service and supply. Moreover, medical cannabis is now projected to contribute EUR 1 billion worth of new exports by 2022.
Find out more about the upcoming edition of the CountryProfiler Malta Report, the most influential publication on doing business and investing in Malta. To participate in this report, contact Garvan Keating on +356 99252229 or email@example.com.
MaltaProfile has listed the companies operating in the medical cannabis space:
Emmac Life Sciences
The Pain Clinic
PT Matic Environmental Services